Dutch biotech Leyden Labs has raised a €30 million equity investment from the European Innovation Council (EIC) Fund and Invest-NL to accelerate the development of its PanFlu nasal spray, as well as the Company’s other mucosal pipeline and platform activities.…
Leiden, 26 September 2025. For the first time, LUMC has used a surgical robot to remove a piece of liver from a living donor and successfully transplant it into a patient. A woman received part of her cousin’s healthy liver.…
Rapidemic has received a $2.7 million grant from the Bill & Melinda Gates Foundation to advance its rapid, electricity-free test for chlamydia and gonorrhea. The portable test delivers results in under 15 minutes, aiming to improve STI diagnostics in low-resource…
We’ve reached a milestone worth celebrating: the official opening of our expanded AMS laboratory. Surrounded by clients, partners, colleagues and key organizations, we marked this moment with pride and dedication. A special thank you to Mayor Peter Heijkoop of Leiden…
The Japanese regulator, the PMDA, waived the requirement for a Phase 1 trial in Japanese subjects for lead asset VMX-C001, enabling it to go straight to Phase 3 development. This rare waiver recognizes the global dataset already generated for VMX-C001…
The Life Sciences Café returned after the summer break with an evening full of fresh ideas, inspiring talks, and new connections. From biomarker wearables to mental health lighting and gamified science, the community came together to explore the future of…
TechTalk: Quantum brought together the life sciences and quantum communities in Leiden to explore how hardware is already being applied to health and science. The event combined expert talks, a visit to the new House of Quantum Leiden, and lively…
LEIDEN, The Netherlands, September 15, 2025 / Biotech Newswire / — ProteoNic, a leader in premium vector technology for biologics and cell and gene therapy, today announced the launch of its novel 2G UNic® transposon platform, available for licensing alongside the expansion of…
The Single-Use Event 2025 in Leiden brought together more than 500 professionals to explore the future of biomanufacturing. With a Basel edition now on the horizon, the momentum behind single-use technologies is going global.
VarmX, a biotechnology company based at the Leiden Bio Science Park (LBSP), has entered into a strategic collaboration and option agreement with global biotechnology leader CSL Limited (ASX:CSL) to advance its lead asset, VMX-C001. The investigational therapy is designed to…
Leiden University Medical Center (LUMC), via its Cairelab initiative, together with the Dutch Police, have been declared winners of the National AI Challenge 2025, organized by KickstartAI and the AI Coalition for the Netherlands (AIC4NL). What they won for: LUMC’s…
Marieke Vinkenoog and Simon Christian Hansmann have been awarded the Krijn Rietveld Memorial Innovation Awards for their research in blood donation and colorectal cancer. Vinkenoog’s work on predictive modeling for donor eligibility and Hansmann’s identification of cancer cells linked to…